SocraTec R&D Concepts in Drug Research and Development GmbH
- Address
- Mainzerhofplatz 14, Erfurt-Altstadt, 99084 Erfurt, Germany
SocraTec R&D Concepts in Drug Research and Development GmbH
SocraTec R&D Concepts in Drug Research and Development GmbH is a specialized clinical research organization with extensive expertise in early-phase drug development and pharmacokinetic studies. The center demonstrates particular proficiency in conducting complex Phase I trials, bioequivalence assessments, and bioavailability studies across diverse therapeutic areas and formulation types.
- Gastrointestinal disorders including idiopathic and diabetic gastroparesis with prokinetic agent evaluation
- Hepatobiliary conditions such as primary sclerosing cholangitis (PSC)
- Novel drug delivery systems including transdermal patches and orodispersible formulations
- Bioequivalence and comparative bioavailability studies for generic and reformulated medications
The facility has significant experience with crossover study designs and multi-dose administration protocols, conducting investigations in both healthy volunteers and patient populations. Their research portfolio includes specialized assessments of factors affecting drug absorption, such as heat exposure, occlusion, and exercise effects on topical formulations. The center's capabilities extend from straightforward bioequivalence trials to complex dose-finding studies evaluating efficacy, safety, and pharmacodynamic endpoints in conditions like gastroparesis and major depressive disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Dr. Falk Pharma GmbH1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Dr. Falk Pharma GmbH3trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in SocraTec R&D Concepts in Drug Research and Development GmbH
lock Showing 1 of 12 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A prospective, randomised, multi-centre, double-blind, placebo-controlled Phase III trial to investigate the efficacy and safety of lozenges with benzydamine hydrochloride and dichlorobenzyl alcohol in the symptomatic treatment of patients suffering from acute pharyngitis | MEDICE Arzneimittel Puetter GmbH & Co. KG | Phase III | Not Yet Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 2,4 DICHLOROBENZYL ALCOHOL | 1 | Unknown | 2026-01-27 | 2026-01-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.